Taro pharmaceutical industries ltd (TARO)
CashFlow / TTM
Mar'12Mar'11
Cash flows from operating activities:
Net income

0

0

Adjustments required to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

0

0

Change in deferred charges and other assets

0

0

Share-based compensation expense

-

0

Accrued severance pay and other long-term liabilities, net

0

-

Change in derivative instruments, net

0

0

Effect of exchange differences on intercompany balances

0

0

Decrease in long-term debt due to currency fluctuations

0

0

Deferred income taxes, net

0

0

(Increase) decrease in trade receivables, net

0

0

Decrease (increase) in other receivables, prepaid expenses and other

0

0

Increase in inventories, net

0

0

Decrease in long-term receivables, prepaid expenses and other

0

0

Decrease (increase) in income tax receivables

-

0

Increase (decrease) in trade payables

0

0

Decrease in other accounts payable and accrued expenses

0

0

Increase (decrease) in income tax payables

0

0

Loss on sale of long-lived assets

0

-

Accrued severance pay and other long-term liabilities, net

-

0

Net cash provided by operating activities

0

0

Cash flows from investing activities:
Purchase of property, plant and equipment

0

0

Proceeds from (investment in) short-term bank deposits, net

0

0

Proceeds from restricted bank deposits

0

-

Proceeds from (investment in) long-term deposits and other assets

0

-

(Investment in) proceeds from marketable securities, net

0

-

Proceeds from sale of long-lived assets

0

-

Net cash used in investing activities

0

0

Cash flows from financing activities:
Proceeds from issuance of shares, net

0

0

Repayment of short-term bank debt, net

-

0

Proceeds from long-term debt

0

0

Net cash used in financing activities

0

0

Effect of exchange rate changes on cash and cash equivalents

0

0

(Decrease) increase in cash and cash equivalents

0

0

Supplemental disclosure of cash flow transactions:
Cash paid during the year for:
Interest

0

0

Income taxes

0

0

Non-cash investing transactions:
Purchase of property, plant and equipment included in accounts payable

0

0